Nemonoxacin Gets FDA Fast Track Designation

TaiGen Biotechnology Company, Limited today announced that the U.S. Food and Drug Administration has granted nemonoxacin Qualified Infectious Disease Product and Fast Track designations for community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections .

http://www.drugs.com/clinical_trials/nemonoxacin-gets-fda-fast-track-designation-16405.html?